Literature DB >> 9879708

Chicken Eyes absent 2 gene: isolation and expression pattern during development.

N Mishima1, S Tomarev.   

Abstract

In all vertebrates studied (human, mouse, chicken), there are at least three genes related to Drosophila eyes absent (eya) gene. The chicken Eyes absent 2 (Eya2) cDNA was isolated from 14 day embryonic chicken lenses, and a complete open reading frame encoding a 59 kDa protein was elucidated. The chicken Eya2 protein is moderately conserved and 78-82% identical to the mouse and human Eya2. The Eya2 gene demonstrated a dynamic expression pattern in different tissues of diverse embryological origin. Expression of Eya2 was first detected at Hamburger and Hamilton stage 9 in the foregut. At later stages of development, Eya2 mRNA was detected in neural crest derivatives (dorsal root ganglia, branchial arches and cranial nerve ganglia). In the cranial placodes, expression of Eya2 was first detected in the nasal pit at stage 13. In the eye, expression of Eya2 was first convincingly detected in neural retina at stage 24 (day 4). The highest level of Eya2 mRNA in the lens was detected around day 9. Eya2 is also expressed in the cornea and iris. Therefore, chicken Eya2, as well as mouse Eya2, is expressed relatively early in the nasal (but not in the lens) placode and may mediate induction of the nasal placode. Expression of Eya2 in the wing and limb buds is consistent with its proposed role in the patterning of limb connective tissues.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9879708

Source DB:  PubMed          Journal:  Int J Dev Biol        ISSN: 0214-6282            Impact factor:   2.203


  11 in total

1.  Synergistic regulation of vertebrate muscle development by Dach2, Eya2, and Six1, homologs of genes required for Drosophila eye formation.

Authors:  T A Heanue; R Reshef; R J Davis; G Mardon; G Oliver; S Tomarev; A B Lassar; C J Tabin
Journal:  Genes Dev       Date:  1999-12-15       Impact factor: 11.361

Review 2.  Genetic and epigenetic mechanisms of gene regulation during lens development.

Authors:  Ales Cvekl; Melinda K Duncan
Journal:  Prog Retin Eye Res       Date:  2007-07-28       Impact factor: 21.198

3.  Canonical Wnt signaling is required for ophthalmic trigeminal placode cell fate determination and maintenance.

Authors:  Rhonda N T Lassiter; Carolynn M Dude; Stephanie B Reynolds; Nichelle I Winters; Clare V H Baker; Michael R Stark
Journal:  Dev Biol       Date:  2007-06-02       Impact factor: 3.582

Review 4.  The Eyes Absent proteins in development and disease.

Authors:  Emmanuel Tadjuidje; Rashmi S Hegde
Journal:  Cell Mol Life Sci       Date:  2012-09-13       Impact factor: 9.261

5.  PRDM1 controls the sequential activation of neural, neural crest and sensory progenitor determinants.

Authors:  Ravindra S Prajapati; Mark Hintze; Andrea Streit
Journal:  Development       Date:  2019-12-16       Impact factor: 6.868

Review 6.  Setting appropriate boundaries: fate, patterning and competence at the neural plate border.

Authors:  Andrew K Groves; Carole LaBonne
Journal:  Dev Biol       Date:  2013-12-07       Impact factor: 3.582

7.  Initiation of olfactory placode development and neurogenesis is blocked in mice lacking both Six1 and Six4.

Authors:  Binglai Chen; Eun-Hee Kim; Pin-Xian Xu
Journal:  Dev Biol       Date:  2008-11-07       Impact factor: 3.582

8.  Specification of GnRH-1 neurons by antagonistic FGF and retinoic acid signaling.

Authors:  Virginie Sabado; Perrine Barraud; Clare V H Baker; Andrea Streit
Journal:  Dev Biol       Date:  2011-12-19       Impact factor: 3.582

9.  Neural crest cells organize the eye via TGF-β and canonical Wnt signalling.

Authors:  Timothy Grocott; Samuel Johnson; Andrew P Bailey; Andrea Streit
Journal:  Nat Commun       Date:  2011       Impact factor: 14.919

10.  Epigenetic silencing of EYA2 in pancreatic adenocarcinomas promotes tumor growth.

Authors:  Audrey Vincent; Seung-Mo Hong; Chaoxin Hu; Noriyuki Omura; Angela Young; Haeryoung Kim; Jun Yu; Spencer Knight; Michael Ayars; Margaret Griffith; Isabelle Van Seuningen; Anirban Maitra; Michael Goggins
Journal:  Oncotarget       Date:  2014-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.